Status:

COMPLETED

Safety and Tolerability of Repeat Courses of IM Alefacept

Lead Sponsor:

Biogen

Conditions:

Chronic Plaque Psoriasis

Eligibility:

All Genders

16+ years

Phase:

PHASE3

Brief Summary

The purpose of this study is to determine whether repeat courses of alefacept, administered intramuscularly, are safe when given to chronic plaque psoriasis patients who are receiving standard dermato...

Eligibility Criteria

Inclusion

  • Written informed consent.
  • At least 16 years of age.
  • Diagnosed with chronic plaque psoriasis and require systemic therapy.
  • CD4+ lymphocyte counts at or above the lower limit of normal for Covance Central Laboratory Services, Inc., unless on a stable dose of prednisone (counts must be at or above 300 cells/mm3).

Exclusion

  • Unstable erthrodermic or pustular psoriasis.
  • Diagnosis of guttate psoriasis.
  • Serious local infection or systemic infection within 3 months prior to first dose of alefacept.
  • Positive for HIV antibody.
  • Known invasive malignancy within 5 years of enrollment. Patients with a history of treated squamous cell and/or basal cell carcinomas limited to the skin are not excluded.
  • Evidence of active tuberculosis.
  • Current treatment for active tuberculosis or tuberculosis prophylaxis.
  • Female patients unwilling to practice effective contraception as defined by the investigator.
  • Female patients who are pregnant or breast-feeding.
  • Current enrollment in any other investigational drug study.
  • Previous participation in this study or previous alefacept studies.

Key Trial Info

Start Date :

December 1 2002

Trial Type :

INTERVENTIONAL

End Date :

December 1 2005

Estimated Enrollment :

400 Patients enrolled

Trial Details

Trial ID

NCT00233662

Start Date

December 1 2002

End Date

December 1 2005

Last Update

August 23 2023

Active Locations (46)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 12 (46 locations)

1

University of California, Irvine

Irvine, California, United States, 92697

2

University of California, San Francisco

San Francisco, California, United States, 94118

3

Clinical Research Specialists, Inc.

Santa Monica, California, United States, 90404

4

University of Connecticut Health Center

Farmington, Connecticut, United States, 06430-6231